Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine which route of administration is better for treatment of opioid overdosed patients


Clinical Trial Description

In intravenous drug abusers (IDUs), as a result of previous intravenous substance abuse, the predictable difficult cannulate exist and cause the delay administration of antidote therapy. Additionally, IDUs are also at increased risk of carrying blood borne infections that could be transmitted to healthcare workers through needle stick injuries. The investigators aimed to compare intranasal administration of naloxone with intravenous route. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01293058
Study type Interventional
Source Isfahan University of Medical Sciences
Contact
Status Completed
Phase Phase 2
Start date March 2007
Completion date June 2007